PetroAlgae and Gevo file for IPO; potential to poison the biofuel and biomaterial IPO pond is high

Last week, PetroAlgae filed for an immodest $200 million IPO with the U.S. Securities and Exchange Commission (SEC). A number of aspects of the filing warrant scrutiny. PetroAlgae grows "selectively bred" strains of duckweed (an aquatic plant similar to algae) in open ponds, and claims a yield up to...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Solidia raises $78 million and names new CEO – will these developments finally lead to commercialization?

News Commentary | May 06, 2021

Solidia Technologies has a new CEO, Bryan Kalbfleisch, along with $78 million more in funding from Imperative Ventures, Zero Carbon Partners, and Breakthrough Energy Ventures, along with existing investors. The company has a promising technology, but the lack of scale‑up and commercialization ... Not part of subscription

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

NovoNutrients raises $9 million to scale its CO₂-to-protein production system

News Commentary | August 10, 2021

The funding, led by Happiness Capital, builds on a previous $4.3 million and brings NovoNutrients' total funding to $9.9 million. E2JDJ, Marinya Capital, and previous investors IndieBio and the Grantham Environmental Trust also participated in the round. NovoNutrients aims to use the funds to scale ... Not part of subscription